...
首页> 外文期刊>Journal of clinical monitoring and computing >Validation of stroke volume and cardiac output by electrical interrogation of the brachial artery in normals: assessment of strengths, limitations, and sources of error
【24h】

Validation of stroke volume and cardiac output by electrical interrogation of the brachial artery in normals: assessment of strengths, limitations, and sources of error

机译:通过正常情况下肱动脉的电讯问验证中风量和心输出量:评估强度,局限性和错误来源

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The goal of this study is to validate a new, continuous, noninvasive stroke volume (SV) method, known as transbrachial electrical bioimpedance velocimetry (TBEV). TBEV SV was compared to SV obtained by cardiac magnetic resonance imaging (cMRI) in normal humans devoid of clinically apparent heart disease. Thirty-two (32) volunteers were enrolled in the study. Each subject was evaluated by echocardiography to assure that no aortic or mitral valve disease was present. Subsequently, each subject underwent electrical interrogation of the brachial artery by means of a high frequency, low amplitude alternating current. A first TBEV SV estimate was obtained. Immediately after the initial TBEV study, subjects underwent cMRI, using steady-state precession imaging to obtain a volumetric estimate of SV. Following cMRI, the TBEV SV study was repeated. Comparing the cMRI-derived SV to that of TBEV, the two TBEV estimates were averaged and compared to the cMRI standard. CO was computed as the product of SV and heart rate. Statistical methods consisted of Bland-Altman and linear regression analysis. TBEV SV and CO estimates were obtained in 30 of the 32 subjects enrolled. Bland-Altman analysis of pre- and post-cMRI TBEV SV showed a mean bias of 2.87 % (2.05 mL), precision of 13.59 % (11.99 mL) and 95 % limits of agreement (LOA) of +29.51 % (25.55 mL) and -23.77 % (-21.45 mL). Regression analysis for pre- and post-cMRI TBEV SV values yielded y = 0.76x + 25.1 and r(2) = 0.71 (r = 0.84). Bland-Altman analysis comparing cMRI SV with averaged TBEV SV showed a mean bias of -1.56 % (-1.53 mL), precision of 13.47 % (12.84 mL), 95 % LOA of +24.85 % (+23.64 mL) and -27.97 % (-26.7 mL) and percent error = 26.2 %. For correlation analysis, the regression equation was y = 0.82x + 19.1 and correlation coefficient r(2) = 0.61 (r = 0.78). Bland-Altman analysis of averaged pre- and post-cMRI TBEV CO versus cMRI CO yielded a mean bias of 5.01 % (0.32 L min(-1)), precision of 12.85 % (0.77 L min(-1)), 95 % LOA of +30.20 % (+0.1.83 L min(-1)) and -20.7 % (-1.19 L min(-1)) and percent error = 24.8 %. Regression analysis yielded y = 0.92x + 0.78, correlation coefficient r(2) = 0.74 (r = 0.86). TBEV is a novel, noninvasive method, which provides satisfactory estimates of SV and CO in normal humans.
机译:这项研究的目的是验证一种新的,连续的,无创的卒中量(SV)方法,称为跨臂生物电阻抗测速(TBEV)。在没有临床明显心脏病的正常人中,将TBEV SV与通过心脏磁共振成像(cMRI)获得的SV进行了比较。三十二(32)名志愿者参加了该研究。通过超声心动图对每个受试者进行评估,以确保不存在主动脉或二尖瓣疾病。随后,每个受试者通过高频,低振幅交流电进行肱动脉的电讯问。获得了第一TBEV SV估计值。最初的TBEV研究结束后,受试者立即进行了cMRI检查,并使用稳态进动图像获得了SV的体积估计值。在进行cMRI后,重复进行TBEV SV研究。将cMRI衍生的SV与TBEV的SV进行比较,将两个TBEV估计值取平均值,并与cMRI标准进行比较。 CO被计算为SV和心率的乘积。统计方法包括Bland-Altman和线性回归分析。 TBEV SV和CO估计值是在32名受试者中的30名获得的。 cMRI之前和之后TBEV SV的Bland-Altman分析显示平均偏差为2.87%(2.05 mL),精密度为13.59%(11.99 mL),一致性(LOA)的95%为+29.51%(25.55 mL)和-23.77%(-21.45mL)。对cMRI前后TBEV SV值的回归分析得出y = 0.76x + 25.1,并且r(2)= 0.71(r = 0.84)。将cMRI SV与平均TBEV SV进行比较的Bland-Altman分析显示平均偏差为-1.56%(-1.53​​ mL),精度为13.47%(12.84 mL),95%LOA为+24.85%(+23.64 mL)和-27.97% (-26.7 mL)和百分误差= 26.2%。对于相关性分析,回归方程为y = 0.82x + 19.1,相关系数r(2)= 0.61(r = 0.78)。对cMRI前后的TBEV CO和cMRI CO进行平均的Bland-Altman分析得出平均偏差为5.01%(0.32 L min(-1)),精度为12.85%(0.77 L min(-1)),95% LOA为+30.20%(+0.1.83 L min(-1))和-20.7%(-1.19 L min(-1)),百分误差= 24.8%。回归分析得出y = 0.92x + 0.78,相关系数r(2)= 0.74(r = 0.86)。 TBEV是一种新颖的无创方法,可为正常人提供令人满意的SV和CO估计值。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号